The Flexibility and Control with SIR-Spheres in your practice

439

 

Dr. Ripal Gandhi and Dr. Nima Kokabi, with Alexander Villalobos acting as moderator, discuss their utilization and best practices with SIR-Spheres through 5 topics:

Dr. Ripal Gandhi and Dr. Nima Kokabi, with Alexander Villalobos acting as moderator, discuss their utilization and best practices with SIR-Spheres through 5 topics:

1/ Order-Map-Treat Program – The ability to Order before you Map to accelerate your SIRT program

“Map on one day and treat the next day is good for the patient, is great for the referring physicians and really interrupts any delays. […] It is also very valuable for me […] I am not tied to treat on a specific day” – R Gandhi

2/ Dose Thresholds – How your treatment intent determines your dosimetry

“When it comes to dosimetry planning, you really need to keep in mind what is the intent of the treatment. […] If you’re doing a curative intent treatment […], then you can actually significantly increase your thresholds” – N Kokabi

3/ Tumor Coverage – The impact of number of spheres on the radiobiological effect

“As you increase the number of particles you’re going to have better coverage and you should have better radiobiological effect” – R Gandhi

4/ FLEXdose Delivery Program – How to personalize activity and coverage with respect to the treated volume

“For radiation segmentectomy I prefer higher activity and fewer particles” R Gandhi “for larger and multifocal distribution I use either 1-day pre-cal (4.6GBq) or day of calibration (3.6GBq)” – N Kokabi

5/ Patient Case

“The ability to take your […] vial and fractionate it […], you just basically draw up what you need, which to me is that flexibility and that personalization up to the time of treatment which is extremely valuable.” – R Gandhi

This video was filmed by Sirtex Medical Limited and is being sponsored for distribution in association with Interventional News.   Biba Medical bears no responsibility for the assets used in the production of this video.


LEAVE A REPLY

Please enter your comment!
Please enter your name here